| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA1908067
Max Phase: Preclinical
Molecular Formula: C16H14N2
Molecular Weight: 234.30
Molecule Type: Small molecule
Associated Items:
Representations
Synonyms (1): Methylbiphenyl-C4-Imidazole
Synonyms from Alternative Forms(1):
Canonical SMILES: Cc1ccc(-c2ccc(-c3ncc[nH]3)cc2)cc1
Standard InChI: InChI=1S/C16H14N2/c1-12-2-4-13(5-3-12)14-6-8-15(9-7-14)16-17-10-11-18-16/h2-11H,1H3,(H,17,18)
Standard InChI Key: BUNPUXYDPSCLHQ-UHFFFAOYSA-N
Associated Targets(Human)
UDP-glucuronosyltransferase 1-6 221 Activities
UDP-glucuronosyltransferase 2B4 139 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 234.30 | Molecular Weight (Monoisotopic): 234.1157 | AlogP: 4.05 | #Rotatable Bonds: 2 |
| Polar Surface Area: 28.68 | Molecular Species: NEUTRAL | HBA: 1 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 2 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 12.67 | CX Basic pKa: 6.30 | CX LogP: 4.04 | CX LogD: 4.01 |
| Aromatic Rings: 3 | Heavy Atoms: 18 | QED Weighted: 0.71 | Np Likeness Score: -0.88 |
References
| 1. Tukey RH, Strassburg CP.. (2000) Human UDP-glucuronosyltransferases: metabolism, expression, and disease., 40 (1): [PMID:10836148] [10.1146/annurev.pharmtox.40.1.581] |
Source
Source(1):